{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:38:42Z","timestamp":1788449922205,"version":"build-2803163510"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosom Med"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Proinflammatory cytokines are associated with bipolar disorder (BD), but less is known about how cytokines function during the interepisode period. This study examined cytokines, mood symptoms, and sleep in individuals with interepisode BD with complaints of insomnia. We also investigated the effects of a BD-specific modification of cognitive behavior therapy for insomnia (CBTI-BP) on cytokine levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty-two adults with interepisode BD type I and insomnia were drawn from a subset of a National Institute of Mental Health funded study. Participants were randomly allocated to CBTI-BP (<jats:italic toggle=\"yes\">n<\/jats:italic>= 11) or psychoeducation (<jats:italic toggle=\"yes\">n<\/jats:italic>= 11). Participants completed a sleep diary, rated self-report measures of mania and depression, and provided samples assayed for interleukin (IL)-6 and tumor necrosis factor soluble receptor 2 (sTNF-R2).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IL-6 was associated with mania symptoms (<jats:italic toggle=\"yes\">r<\/jats:italic><jats:sub>s<\/jats:sub>= 0.44,<jats:italic toggle=\"yes\">p<\/jats:italic>= .041) and total sleep time (<jats:italic toggle=\"yes\">r<\/jats:italic><jats:sub>s<\/jats:sub>= \u22120.49,<jats:italic toggle=\"yes\">p<\/jats:italic>= .026). IL-6 was related to depression symptoms at the trend level (<jats:italic toggle=\"yes\">r<\/jats:italic><jats:sub>s<\/jats:sub>= 0.43,<jats:italic toggle=\"yes\">p<\/jats:italic>= .052). sTNF-R2 was not significantly related to mood or sleep measures. From pretreatment to posttreatment, CBTI-BP compared with psychoeducation was associated with a nonsignificant, large effect size decrease in IL-6 (<jats:italic toggle=\"yes\">z<\/jats:italic>= \u22121.61,<jats:italic toggle=\"yes\">p<\/jats:italic>= .13,<jats:italic toggle=\"yes\">d<\/jats:italic>= \u22120.78) and a nonsignificant, small-medium effect size decrease in sTNF-R2 (<jats:italic toggle=\"yes\">z<\/jats:italic>= \u22120.79,<jats:italic toggle=\"yes\">p<\/jats:italic>= .44,<jats:italic toggle=\"yes\">d<\/jats:italic>= \u22120.38).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These findings provide preliminary evidence that IL-6 is related to mania symptoms and shorter total sleep time in interepisode BD. A treatment that targets sleep in BD could potentially decrease IL-6 although replication is warranted.<\/jats:p><\/jats:sec>","DOI":"10.1097\/psy.0000000000000529","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T23:44:26Z","timestamp":1505346266000},"page":"87-94","source":"Crossref","is-referenced-by-count":26,"title":["Proinflammatory Cytokines, Mood, and Sleep in Interepisode Bipolar Disorder and Insomnia: A Pilot Study With Implications for Psychosocial Interventions"],"prefix":"10.1097","volume":"80","author":[{"given":"Emily A.","family":"Dolsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane M.","family":"Soehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison G.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230824","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"bib3-20230824","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1176\/appi.ajp.162.1.50","article-title":"Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems","volume":"162","year":"2005","journal-title":"Am J Psychiatry"},{"key":"bib4-20230824","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1017\/S0033291797005333","article-title":"The epidemiology of DSM-III-R bipolar I disorder in a general population survey","volume":"27","year":"1997","journal-title":"Psychol Med"},{"key":"bib5-20230824","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11325-008-0215-5","article-title":"Sleep in bipolar patients","volume":"13","year":"2009","journal-title":"Sleep Breath"},{"key":"bib6-20230824","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"bib7-20230824","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PSY.0000000000000339","article-title":"Depression phenotype, inflammation, and the brain: implications for future research","volume":"78","year":"2016","journal-title":"Psychosom Med"},{"key":"bib8-20230824","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PSY.0000000000000311","article-title":"The role of brain structure and function in the association between inflammation and depressive symptoms: a systematic review","volume":"78","year":"2016","journal-title":"Psychosom Med"},{"key":"bib9-20230824","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","year":"2011","journal-title":"Biol Psychiatry"},{"key":"bib10-20230824","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1038\/tp.2013.27","article-title":"Anxiety disorders and inflammation in a large adult cohort","volume":"3","year":"2013","journal-title":"Transl Psychiatry"},{"key":"bib11-20230824","first-page":"1","article-title":"Cytokine levels in panic disorder: evidence for a dose-response relationship","volume":"79","year":"2016","journal-title":"Psychosom Med"},{"key":"bib12-20230824","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cncr.21234","article-title":"Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome","volume":"104","year":"2005","journal-title":"Cancer"},{"key":"bib13-20230824","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2008.01.005","article-title":"Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients","volume":"195","year":"2008","journal-title":"J Neuroimmunol"},{"key":"bib14-20230824","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature","volume":"70","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"bib15-20230824","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","year":"2013","journal-title":"J Affect Disord"},{"key":"bib16-20230824","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","year":"2013","journal-title":"J Psychiatr Res"},{"key":"bib17-20230824","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder","volume":"261","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"bib18-20230824","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","year":"2006","journal-title":"J Affect Disord"},{"key":"bib19-20230824","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","year":"2011","journal-title":"J Psychiatr Res"},{"key":"bib20-20230824","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2010.00822.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor","volume":"12","year":"2010","journal-title":"Bipolar Disord"},{"key":"bib21-20230824","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hup.2301","article-title":"Levels of TNF-\u03b1, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder","volume":"28","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"bib22-20230824","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","year":"2009","journal-title":"J Affect Disord"},{"key":"bib23-20230824","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jad.2010.04.027","article-title":"Cytokine levels in euthymic bipolar patients","volume":"126","year":"2010","journal-title":"J Affect Disord"},{"key":"bib24-20230824","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0327(94)90012-4","article-title":"Immune parameters in euthymic bipolar patients and normal volunteers","volume":"32","year":"1994","journal-title":"J Affect Disord"},{"key":"bib25-20230824","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1037\/a0024946","article-title":"A test of the bidirectional association between sleep and mood in bipolar disorder and insomnia","volume":"121","year":"2012","journal-title":"J Abnorm Psychol"},{"key":"bib26-20230824","first-page":"24","article-title":"The importance of subsyndromal symptoms in bipolar disorder","volume":"65","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"bib27-20230824","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jpsychires.2011.08.003","article-title":"Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia","volume":"45","year":"2011","journal-title":"J Psychiatr Res"},{"key":"bib28-20230824","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(00)00252-4","article-title":"Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania","volume":"64","year":"2001","journal-title":"J Affect Disord"},{"key":"bib29-20230824","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","article-title":"The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs","volume":"7","year":"2002","journal-title":"Mol Psychiatry"},{"key":"bib30-20230824","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2004.08.005","article-title":"T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients","volume":"129","year":"2004","journal-title":"Psychiatry Res"},{"key":"bib31-20230824","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers","volume":"29","year":"1995","journal-title":"J Psychiatr Res"},{"key":"bib32-20230824","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1399-5618.2006.00330.x","article-title":"The prospective impact of sleep duration on depression and mania","volume":"8","year":"2006","journal-title":"Bipolar Disord"},{"key":"bib33-20230824","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0165-1781(96)02854-5","article-title":"Relationship between sleep and mood in patients with rapid-cycling bipolar disorder","volume":"63","year":"1996","journal-title":"Psychiatry Res"},{"key":"bib34-20230824","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbi.2005.06.007","article-title":"Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study","volume":"20","year":"2006","journal-title":"Brain Behav Immun"},{"key":"bib35-20230824","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1210\/jcem.82.5.3950","article-title":"Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity","volume":"82","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"bib36-20230824","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/PSY.0000000000000340","article-title":"Sleep and inflammation during adolescence","volume":"78","year":"2016","journal-title":"Psychosom Med"},{"key":"bib37-20230824","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/PSY.0000000000000312","article-title":"Actigraphy- and polysomnography-measured sleep disturbances, inflammation, and mortality among older men","volume":"78","year":"2016","journal-title":"Psychosom Med"},{"key":"bib38-20230824","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopsych.2015.05.014","article-title":"sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation","volume":"80","year":"2016","journal-title":"Biol Psychiatry"},{"key":"bib39-20230824","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cyto.2011.06.002","article-title":"Effect of one night of sleep loss on changes in tumor necrosis factor alpha (TNF-\u03b1) levels in healthy men","volume":"56","year":"2011","journal-title":"Cytokine"},{"key":"bib40-20230824","doi-asserted-by":"crossref","first-page":"E253","DOI":"10.1152\/ajpendo.00651.2005","article-title":"Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion","volume":"292","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"bib41-20230824","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1067\/mai.2001.112270","article-title":"Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight","volume":"107","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"bib42-20230824","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1684\/ecn.2014.0356","article-title":"Effect of acute sleep deprivation and recovery on Insulin-like Growth Factor-I responses and inflammatory gene expression in healthy men","volume":"25","year":"2014","journal-title":"Eur Cytokine Netw"},{"key":"bib43-20230824","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/sleep\/30.9.1145","article-title":"Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers","volume":"30","year":"2007","journal-title":"Sleep"},{"key":"bib44-20230824","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1053\/meta.2002.33357","article-title":"Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime","volume":"51","year":"2002","journal-title":"Metabolism"},{"key":"bib46-20230824","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PSY.0000000000000363","article-title":"Reciprocal relationship between sleep macrostructure and evening and morning cellular inflammation in rheumatoid arthritis","volume":"79","year":"2017","journal-title":"Psychosom Med"},{"key":"bib47-20230824","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.mehy.2013.09.025","article-title":"Disturbed sleep in bipolar disorder is related to an elevation of IL-6 in peripheral monocytes","volume":"81","year":"2013","journal-title":"Med Hypotheses"},{"key":"bib48-20230824","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1037\/a0038655","article-title":"Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial","volume":"83","year":"2015","journal-title":"J Consult Clin Psychol"},{"key":"bib49-20230824","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0447.1991.tb03123.x","article-title":"High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I)","volume":"84","year":"1991","journal-title":"Acta Psychiatr Scand"},{"key":"bib50-20230824","first-page":"A265","article-title":"Reliability and validity of the Duke Structured Interview for Sleep Disorders for insomnia screening","volume":"32","year":"2009","journal-title":"Sleep"},{"key":"bib51-20230824","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","year":"1978","journal-title":"Br J Psychiatry"},{"key":"bib52-20230824","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","year":"1996","journal-title":"Psychol Med"},{"key":"bib53-20230824","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5665\/sleep.1642","article-title":"The consensus sleep diary: standardizing prospective sleep self-monitoring","volume":"35","year":"2012","journal-title":"Sleep"},{"key":"bib54-20230824","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/sleep\/29.9.1155","article-title":"Recommendations for a standard research assessment of insomnia","volume":"29","year":"2006","journal-title":"Sleep"},{"key":"bib55-20230824","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1532-5415.2005.00642.x","article-title":"Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease","volume":"54","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"bib56-20230824","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.psy.0000149259.72488.09","article-title":"Inflammatory markers and sleep disturbance in major depression","volume":"67","year":"2005","journal-title":"Psychosom Med"},{"key":"bib57-20230824","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/CDLI.5.4.507-512.1998","article-title":"Oral fluids as an alternative to serum for measurement of markers of immune activation","volume":"5","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"bib58-20230824","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/01.PSY.0000097338.75454.29","article-title":"Immunological effects of induced shame and guilt","volume":"66","year":"2004","journal-title":"Psychosom Med"},{"key":"bib59-20230824","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1055-3290(98)80062-9","article-title":"Oral mucosal transudate testing for HIV-1 antibodies: a clinical update","volume":"9","year":"1998","journal-title":"J Assoc Nurses AIDS Care"},{"key":"bib60-20230824","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.1997.03540270080030","article-title":"Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing","volume":"277","year":"1997","journal-title":"JAMA J Am Med Assoc"},{"key":"bib61-20230824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-1759(96)00090-7","article-title":"A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-alpha","volume":"195","year":"1996","journal-title":"J Immunol Methods"},{"key":"bib62-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","article-title":"Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis","volume":"54","year":"1995","journal-title":"Eur J Haematol"},{"key":"bib63-20230824","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","article-title":"Design and analysis of pilot studies: recommendations for good practice","volume":"10","year":"2004","journal-title":"J Eval Clin Pract"},{"key":"bib64-20230824","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2288-14-41","article-title":"The statistical interpretation of pilot trials: should significance thresholds be reconsidered?","volume":"14","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"bib65-20230824","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0956797613504966","article-title":"The new statistics: why and how","volume":"25","year":"2014","journal-title":"Psychol Sci"},{"key":"bib67-20230824","first-page":"1542","article-title":"Measures of clinical significance","volume":"42","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"bib68-20230824","first-page":"411","article-title":"What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models","volume":"66","year":"2004","journal-title":"Psychosom Med"},{"key":"bib70-20230824","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbi.2009.04.005","article-title":"To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers","volume":"23","year":"2009","journal-title":"Brain Behav Immun"},{"key":"bib71-20230824","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jad.2004.01.007","article-title":"Cytokine production in bipolar affective disorder patients under lithium treatment","volume":"82","year":"2004","journal-title":"J Affect Disord"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006842-201801000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:51:09Z","timestamp":1750877469000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006842-201801000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0000000000000529","relation":{},"ISSN":["1534-7796","0033-3174"],"issn-type":[{"value":"1534-7796","type":"electronic"},{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}